Radioactive Yttrium 90: A review of its properties, biological behavior, and clinical uses

References

• Andrews G. A., Kniseley R. M., Palmer E. L., Kretchmar A. L. Therapeutic usefulness of radioactive colloids: Comparative value of gold 198, chromic phosphate (P-32), yttrium — 90, and lutecium 177. Proc. United Nations Confer. Peaceful Uses Atomic Energy (New York) 1956; 10: 122
   Google Scholar
• Ariel I. M. Treatment of ovarian cancer with radioactive isotopes. Amer. J. Roentgenol. 1962; 88: 877
   Web of Science ®Google Scholar
• Bellion B., Robecchi E., Cavagnino L. Risultati e considerazioni sul trattamento dei tumori maligni dell'ovaio con oro radioattivo colloidale. Minerva Ginec. 1960; 12: 1023
   Google Scholar
• Cook G. B., Miles B. J., Neal F. E., Thomson A. R. A comparison of the tissue distribution of colloidal yttrium 90 and gold 198 in mice after intraperitoneal injection. Strahlentherapie Sonderband 1958; 38: 348
   Google Scholar
• Dobson E. L., Jones H. B. The behavior of intravenously injected particulate material. Its rate of disappearance from the blood stream as a measure of liver blood flow. Acta med. scand. Suppl. 1951; 273
   Google Scholar
• Warner G. F., Finney C. R., Johnson M. E. The measurement of liver circulation by means of the colloid disappearance rate. I. Liver blood flow in normal young men. Circulation 1953; VII: 690
   Google Scholar
• Gofman J. W., Jones H. B., et al. Studies with colloids containing radioisotopes of yttrium, zirconium, columbium, and lanthanum II. The controlled selective localization of radioisotopes of yttrium, zirconium and columbium in the bone marrow, liver, and spleen. J. Lab. clin. Med. 1949; 34: 305
   PubMed Web of Science ®Google Scholar
• Doering R. F., Tucker W. D., Stang L. G., Jr. A rapid method for the detection of Sr 90 contamination in Y 90. J. Inorg. Nuclear Chem. 1960; 15: 215
   Web of Science ®Google Scholar
• Dubois K. P. Chemical toxicity of salts of lanthanum, yttrium, and some other rare metals to animals U. S. Atomic Energy Comm. Report ORINS 12 (1956). Technical Information Service Extension, Oak Ridge, Tennessee, USA. Dudley H. C Influence of chelates on the metabolism of radioyttrium (Y-90). J. Lab. clin. Med. 1955; 45: 792
   PubMedGoogle Scholar
• Dubois K. P., Greenberg J. Influence of chelates on the metabolism of radioyttrium (Y-90) II. J. Lab. clin. Med. 1956; 47: 891
   PubMedGoogle Scholar
• Einhorn J., Larsson L. G., Ragnhult I. Radioactive yttrium (Y-90) as a possible adjunct in the treatment of papillomatosis of the urinary bladder. Acta radiol. 1955; 43: 298
   PubMed Web of Science ®Google Scholar
• Gofman J. W. Studies with colloids containing radioisotopes of yttrium, zirconium, columbium, and lanthanum I. The chemical principles and methods involved in preparation of colloids of yttrium, zirconium, columbium, and lanthanum. J. Lab. clin. Med. 1949; 34: 297
   PubMed Web of Science ®Google Scholar
• Goldie H., Disher S. C., Smith C. S., Davis F. B. Prevention of peritoneal free (ascites) tumor cell growth and implantation by pretreatment with radioactive yttrium. Proc. Soc. exp. Biol. 1959; 102: 295
   PubMed Web of Science ®Google Scholar
• Greenberg J., Dudley H. C. Circumscribed neoplastic lesions—A new modality for therapy. Amer. J. Proctol. 1957; 8: 216
   PubMedGoogle Scholar
• Greenberg J., Sawitsky A. Therapy of leukemia and related conditions with radioyttrium (Y-90). Proc. Amer. Ass. Cancer Res. 1958; 2: 303
   Google Scholar
• Sawitsky A., Dudley H. C. et coll. Therapy of polycythemia vera with radioyttrium (Y-90). J. Nuclear Med. 1962; 3: 18
   PubMed Web of Science ®Google Scholar
• Weisfuse L., et al. Therapy of multiple myeloma with radioyttrium (Y-90). J. Lab. clin. Med. 1962; 59: 898
   PubMed Web of Science ®Google Scholar
• Greenwald E., Hart H. E., Rosoff B. et coll. Determination of body spaces and renal clearances with yttrium chelates in man. Int. J. appl. Radiat. 1960; 8: 198
   Google Scholar
• Halpern B. N., Benacerraf B., Delafresnaye J. F. Physiopathology of the reticulo-endothelial system. Blackwell Scient. Publ., Oxford 1957
   Google Scholar
• Hart H. E., Greenberg J., Lewin R. Metabolism of lanthanum and yttrium chelates. J. Lab. clin. Med. 1955; 46: 182
   PubMed Web of Science ®Google Scholar
• Kawin B. Metabolism of radioyttrium. (Letter to the editor.). Arch. Biochem. 1953; 45: 230
   PubMed Web of Science ®Google Scholar
• Kroll H., Korman S., Siegel E. et coll. Excretion of yttrium and lanthanum chelates of cyclohexane 1, 2—transdiamine tetraacetic acid and diethylenetriamine pentaacetic acid in man. Nature 1957; 180: 919
   PubMed Web of Science ®Google Scholar
• Kyker G. C. Biological consideration of distribution. Amer. J. med. Sci. 1954; 227: 572
   PubMed Web of Science ®Google Scholar
• Cress E. A. Acute toxicity of yttrium, lanthanum, and other rare earths. Arch. indust. Hlth. 1957; 16: 475
   PubMedGoogle Scholar
• Lewin R., Hart H. E., Greenberg et coll. Biological studies on stable and radioactive rare earth compounds III Distribution of radioactive yttrium in normal and in ascites-tumor bearing mice, and in cancer patients with serous effusions. J. nat. Cancer Inst. 1954; 15: 131
   PubMedGoogle Scholar
• Lewin R., Hart H. E., Greenberg et coll. Distribution of yttrium-90 upon systemic and intracavitary administration, and its modification by chelating agents. Radioisotope Conference. 1954. Butterworths Scientific Publications, London, Vol. 1
   Google Scholar
• Mac Donald N. S., Nusbaum R. E., Alexander G. V., et al. The skeletal deposition of yttrium. J. biol. Chem. 1952; 195: 837
   PubMed Web of Science ®Google Scholar
• Mayer S. W., Morton M. E. Preparation and distribution of yttrium-90 fluoride. U. S. Atomic Energy Comm. 1956, Report ORINS-12. Technical Information Service Extension, Oak Ridge, Tennessee, U. S. A.
   Google Scholar
• Moseley R. D., Jr, Harper P. V., Jr. Pernasal transsphenoidal yttrium 90 hypophysectomy: present status. J. Nucl. Med. 1961; 2: 137
   Web of Science ®Google Scholar
• Müller J. H. Erste Fünfjahresergebnisse der routinemässigen (obligaten) intraperitonealen Behandlung des Ovarial-Karzinoms mit kolloidalem Radiogold. Wien. med. Wsch. 1959; 109: 20
   PubMedGoogle Scholar
• Notter G. A technique for destruction of the hypophysis using Y90-spheres. A radiologic, endocrine and histologic study. Acta radiol 1959, Suppl. No. 184
   Google Scholar
• Ramsden E. N. A review of experimental work on radio-yttrium, comprising: 1. The tissue distribution. 2. The mechanism of deposition in bone, and 3. The state in the blood. Int. J. Radiat. Biol. 1961; 3: 399
   Web of Science ®Google Scholar
• Rose R. G. Intracavitary radioactive colloidal gold in the management of ovarian carcinoma. Obstet. Gynec. 1961; 18: 557
   PubMed Web of Science ®Google Scholar
• Rosoff B., Lewin R., Hart H. E. et coll. Interaction of yttrium compounds with serum and serum constituents in vitro. Arch. Biochem. 1958; 78: 1
   PubMed Web of Science ®Google Scholar
• Ritter S., Sullivan K. et coll. Effect of chelating agents on the removal of yttrium and lanthanum from man. Hlth Phys. 1961; 6: 177
   PubMedGoogle Scholar
• Sheer K. E. Radioaktives Yttrium Y-90 als Strahlenquelle fur intraperitoneale und intrapleurale Applikation. Strahlentherapie 1956; 101: 283
   PubMedGoogle Scholar
• Siegel E. P., Hart H. E., Brothers M., et al. Radioyttrium (Y-90) for the palliative treatment of effusions due to malignancy. J. Amer. med. Ass. 1956; 161: 499
   PubMed Web of Science ®Google Scholar
• Speer R. J., Hill J. M., Denton A. D., Jr. Colloidal yttrium hydroxide Y-90 and yttrium phosphate (Y-90) Preparation and tissue distribution following intravenous administration. Proc. Soc. exp. Biol. 1961; 106: 444
   Web of Science ®Google Scholar
• Spencer H. Private communication with L. Walker regarding results on the therapeutic use of yttrium. 1963
   Google Scholar
• Steidle H., Ding M. Beiträge zur Pharmakologie der seltenen Erdmetalle II. Über das Yttrium. Arch. exp. Path. Pharmakol. 1929; 142: 273
   Google Scholar
• Tucker W. D. 1960, Radioisotopic cows. U. S. Atomic Energy Report (USAEC). Brookhaven National Laboratory (BNL) Report No. BNL 4908
   Google Scholar
• Vickery R. C. The chemistry of yttrium and scandium. Pergamon Press, New York 1960; Vol. 2, Intern. Series Monographs Inorg. Chem.
   Google Scholar
• Walker L. A. Localization of radioactive colloids in lymph nodes. J. Lab. clin. Med. 1950; 36: 440
   PubMed Web of Science ®Google Scholar
• Walter J., Jones J. C., Fisher M. Radioactive colloidal yttrium silicate in the treatment of malignant effusions I. Clinical aspects and investigations. Brit. J. Radiol. 1961; 34: 337
   PubMed Web of Science ®Google Scholar
• Woodward E. R., Harper P. V., Jr. The prevention of peritoneal tumor implants by radioactive colloidal gold (Au-198). (Surgical Forum of the American College of Surgeons.). W. B. Saunders Company, Philadelphia 1953
   Google Scholar